SecBot SecBot
PRESS-RELEASE ·Filed Nov 4, 2026

COAG

Hemab Therapeutics, Inc.
NEUTRAL
Impact 4/10
Processed56m ago Wirepress-3395417
Press release · FDA

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3395417
16 reports for COAG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for COAG, sortable and filterable
TypeNow
Nov 4, 2026
today
Press Release
NEUTRAL ★ 4/10
$41.90awaiting T+20awaiting T+20$44.49 (+6.18%)
Sep 25, 2026
5w ago
3
NEUTRAL ★ 2/10
$33.12 $36.02▲ +8.76%▲ +8.79%$44.49 (+34.33%)
Sep 17, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$41.22 $32.52▼ −21.11%▼ −22.56%$44.49 (+7.93%)
Aug 11, 2026
12w ago
8-K
BULLISH ★ 7/10
$49.87 $44.50▼ −10.77%▼ −9.71%$44.49 (−10.79%)
Jun 17, 2026
19w ago
Insider Buy
NEUTRAL ★ 2/10
$29.24 $44.53▲ +52.29%▲ +51.76%$44.49 (+52.15%)
May 21, 2026
23w ago
Press Release
NEUTRAL ★ 5/10
$26.30 $31.83▲ +21.03%▲ +20.69%$44.49 (+69.16%)
May 4, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$25.00 $27.47▲ +9.88%▲ +4.93%$44.49 (+77.96%)
Apr 30, 2026
26w ago
Press Release
NEUTRAL ★ 5/10
$34.00 $27.13▼ −20.21%▼ −25.47%$44.49 (+30.85%)
Apr 30, 2026
26w ago
3
NEUTRAL ★ 3/10
$34.00 $27.13▼ −20.21%▼ −25.47%$44.49 (+30.85%)
Apr 30, 2026
26w ago
3
NEUTRAL ★ 3/10
$34.00 $27.13▼ −20.21%▼ −25.47%$44.49 (+30.85%)
Showing 10 of 16

US Market Status

Market Open · Closes in 5h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026

Fresh COAG Intelligence

Analysis is for subscribers only.

Subscribe for Full Access